These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 8269392)

  • 1. Antifungal susceptibility testing.
    Rex JH; Pfaller MA; Rinaldi MG; Polak A; Galgiani JN
    Clin Microbiol Rev; 1993 Oct; 6(4):367-81. PubMed ID: 8269392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antifungal susceptibility testing.
    Hoffman HL; Pfaller MA
    Pharmacotherapy; 2001 Aug; 21(8 Pt 2):111S-123S. PubMed ID: 11501985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests.
    Espinel-Ingroff A; Kish CW; Kerkering TM; Fromtling RA; Bartizal K; Galgiani JN; Villareal K; Pfaller MA; Gerarden T; Rinaldi MG
    J Clin Microbiol; 1992 Dec; 30(12):3138-45. PubMed ID: 1452697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of antifungal susceptibility testing and clinical relevance.
    Espinel-Ingroff A; Barchiesi F; Hazen KC; Martinez-Suarez JV; Scalise G
    Med Mycol; 1998; 36 Suppl 1():68-78. PubMed ID: 9988494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal susceptibility methods and clinical implications of antifungal resistance.
    Espinel-Ingroff A; Warnock DW; Vazquez JA; Arthington-Skaggs BA
    Med Mycol; 2000; 38 Suppl 1():293-304. PubMed ID: 11204157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal susceptibility testing. New technology and clinical applications.
    Pfaller MA; Yu WL
    Infect Dis Clin North Am; 2001 Dec; 15(4):1227-61. PubMed ID: 11780273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.
    Gehrt A; Peter J; Pizzo PA; Walsh TJ
    J Clin Microbiol; 1995 May; 33(5):1302-7. PubMed ID: 7615745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current status of studies on sensitivity to antifungal agents].
    Martín Mazuelos E
    Enferm Infecc Microbiol Clin; 1992; 10(6):366-71. PubMed ID: 1391021
    [No Abstract]   [Full Text] [Related]  

  • 9. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
    Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of in vitro antifungal susceptibility testing.
    Espinel-Ingroff A
    Rev Esp Quimioter; 2000 Jun; 13(2):161-6. PubMed ID: 10918088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi.
    Espinel-Ingroff A; Bartlett M; Bowden R; Chin NX; Cooper C; Fothergill A; McGinnis MR; Menezes P; Messer SA; Nelson PW; Odds FC; Pasarell L; Peter J; Pfaller MA; Rex JH; Rinaldi MG; Shankland GS; Walsh TJ; Weitzman I
    J Clin Microbiol; 1997 Jan; 35(1):139-43. PubMed ID: 8968895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal drug resistance: does it matter?
    Rogers TR
    Int J Infect Dis; 2002 Mar; 6 Suppl 1():S47-53. PubMed ID: 12044289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential use of BacT/Alert automated blood culture system for antifungal susceptibility testing.
    Hazen KC; Chery MP; Han Y
    J Clin Microbiol; 1994 Mar; 32(3):848-50. PubMed ID: 8195407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility testing of fungi and correlation with clinical outcome.
    Ghannoum MA
    J Chemother; 1997 May; 9 Suppl 1():19-24. PubMed ID: 9248959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal susceptibility testing: a primer for clinicians.
    Kuper KM; Coyle EA; Wanger A
    Pharmacotherapy; 2012 Dec; 32(12):1112-22. PubMed ID: 23165897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal susceptibility testing: technical advances and potential clinical applications.
    Pfaller MA; Rex JH; Rinaldi MG
    Clin Infect Dis; 1997 May; 24(5):776-84. PubMed ID: 9142769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal susceptibility testing.
    Gianinni MA; Pearson T; Patrick CC
    Pediatr Infect Dis J; 1999 Nov; 18(11):1021-2. PubMed ID: 10571444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to Antifungal Drugs.
    Ben-Ami R; Kontoyiannis DP
    Infect Dis Clin North Am; 2021 Jun; 35(2):279-311. PubMed ID: 34016279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mycoses].
    Yamazumi T; Furuta I
    Rinsho Byori; 2002 Sep; 50(9):853-9. PubMed ID: 12386962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.